Report Confirms FDA is scaring off Venture Capital investments in Medtech

Report Confirms Venture Capital at Risk in Medtech (Orthopedic Design & Technology)
Venture capitalists in the United States are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investment away from the United States toward Europe and Asia, according to a report released today by the National Venture Capital Association’s MedIC Coalition.
What’s the reason? The survey of more than 150 venture capital firms pointed fingers at U.S. Food and Drug Administration (FDA) regulatory challenges as b...